These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1516520)

  • 41. [A rapid radioimmunoassay method for the determination of blood insulin and its application in the intraoperative localization of insulinoma].
    Ursich MJ; Fukui RT; Pupo Ade A; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):211-5. PubMed ID: 2854907
    [No Abstract]   [Full Text] [Related]  

  • 42. Glucagon-insulin interactions in patients with insulin-producing pancreatic islet lesions.
    Cloutier MG; Pek S; Crowther RL; Floyd JC; Faians SS
    J Clin Endocrinol Metab; 1979 Feb; 48(2):201-6. PubMed ID: 372202
    [No Abstract]   [Full Text] [Related]  

  • 43. A unique form of circulating insulin in human islet cell carcinoma.
    Gorden P; Freychet P; Nankin H
    J Clin Endocrinol Metab; 1971 Dec; 33(6):983-7. PubMed ID: 4332614
    [No Abstract]   [Full Text] [Related]  

  • 44. C-peptide during the prolonged fast in insulinoma.
    Service FJ; O'Brien PC; McMahon MM; Kao PC
    J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mithramycin for hypoglycemia in malignant insulinoma.
    Kiang DT; Frenning DH; Bauer GE
    N Engl J Med; 1978 Jul; 299(3):134-5. PubMed ID: 207984
    [No Abstract]   [Full Text] [Related]  

  • 46. Proinsulin and insulin content of subcellular fractions from an islet adenoma.
    Lindall AW; Wong ET; Sorenson RL; Steffes MW
    J Clin Endocrinol Metab; 1972 Apr; 34(4):718-29. PubMed ID: 4335108
    [No Abstract]   [Full Text] [Related]  

  • 47. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fasting insulin levels in normal Kenyan Africans and a case report on insulinoma.
    Ogutu EO; Orinda DA
    East Afr Med J; 1989 Dec; 66(12):830-3. PubMed ID: 2558874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Insulin assay in insulinoma].
    Zeng XJ
    Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
    [No Abstract]   [Full Text] [Related]  

  • 50. Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin.
    Hutton JC; Davidson HW; Grimaldi KA; Peshavaria M
    Biochem J; 1987 Jun; 244(2):449-56. PubMed ID: 3311030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
    Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
    Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Monitoring blood glucose level in patients with insulinoma during the postoperative period: 3 case reports].
    Li GL; Ge W; Lu RY
    Zhonghua Hu Li Za Zhi; 1997 Oct; 32(10):575-7. PubMed ID: 9495998
    [No Abstract]   [Full Text] [Related]  

  • 53. Asymptomatic insulinoma: a case report and autopsy series.
    Kishi S; Sakamoto K; Mori M; Isogawa A; Shiba T
    Diabetes Res Clin Pract; 2012 Dec; 98(3):445-51. PubMed ID: 23084041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologically active circulating proinsulin-like materials from an islet cell carcinoma patient.
    Lazarus NR; Gutman RA; Penhos JC; Recant L
    Diabetologia; 1972 Apr; 8(2):131-5. PubMed ID: 4337959
    [No Abstract]   [Full Text] [Related]  

  • 55. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
    Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
    Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoreactive insulin assay in insulinoma.
    Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
    Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
    [No Abstract]   [Full Text] [Related]  

  • 57. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editorial: Diagnosis of insulinoma.
    Lancet; 1974 Aug; 2(7877):385-6. PubMed ID: 4136659
    [No Abstract]   [Full Text] [Related]  

  • 59. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
    Myers NC; Andrews GA; Chard-Bergstrom C
    Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of hyperinsulinaemia at the termination of the prolonged fast.
    Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C
    Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.